Ferroxidase I and IIIN CAPD Patients | Zendy

Agroyannis Basil | Zendy; Yatzidis Hippocrates | Zendy; Matrona Frangos-Plemenos | Zendy; Dimitrios Koutsicos | Zendy; Katirtzoglou Antony | Zendy; Sarris Evangelos | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ferroxidase I and IIIN CAPD Patients

Author(s) -

Agroyannis Basil,

Yatzidis Hippocrates,

Matrona Frangos-Plemenos,

Dimitrios Koutsicos,

Katirtzoglou Antony,

Sarris Evangelos

Publication year - 1987

Publication title -

peritoneal dialysis international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.79

H-Index - 83

eISSN - 1718-4304

pISSN - 0896-8608

DOI - 10.1177/089686088700700412

Subject(s) - ceruloplasmin , peritoneal dialysis , continuous ambulatory peritoneal dialysis , medicine , peritoneal fluid , ambulatory , chemistry , gastroenterology

In 32 patients undergoing continuous ambulatory peritoneal dialysis (CAPD) and in 56 healthy subjects, ferroxidase I (ceruloplasmin) and ferroxidase II activity were estimated in serum; in 12 of the 32, it was also measured in peritoneal fluid. Serum ferroxidase I was normal, while ferroxidase II was significantly increased. Peritoneal fluid contains appreciable amounts of ferroxidase I, but no ferroxidase II. The serum ferroxidase profile of patients on CAPD differs from that of hemodialysis (HD) patients; in the latter, both ferroxidases are significantly increased. This difference could be accounted by the loss offerroxidase I in the peritoneal fluid.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research